CN102488788A - Medicinal composition for treating asthma in children - Google Patents
Medicinal composition for treating asthma in children Download PDFInfo
- Publication number
- CN102488788A CN102488788A CN201110407152XA CN201110407152A CN102488788A CN 102488788 A CN102488788 A CN 102488788A CN 201110407152X A CN201110407152X A CN 201110407152XA CN 201110407152 A CN201110407152 A CN 201110407152A CN 102488788 A CN102488788 A CN 102488788A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- children
- pharmaceutical composition
- asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a medicinal composition for treating asthma in children. The medicine composition consists of the following Chinese herbal medicines in part by weight: 1 to 10 parts of bupleurum chinense, 1 to 10 parts of scutellaria baicalensis, 1 to 10 parts of stephania tetrandra, 1 to 5 parts of platycodon grandiflorum, 1 to 10 parts of schisandra chinensis, 1 to 5 parts of angelica sinensis, 1 to 10 parts of frankincense, 1 to 10 parts of weeping forsythia, 1 to 5 parts of girald pteroxygonum root, and 1 to 10 parts of indian stringbush root. The medicinal composition is reasonable in composition, and accurate in curative effect, and can effectively treat asthma in children.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of pharmaceutical composition of treating infantile asthma.
Background technology
Infantile asthma is the common chronic respiratory tract disease of child.Its sickness rate is worldwide in rising trend in recent years, and the prevalence of developed country's childhood asthma is up to more than 10%.The average prevalence of Chinese children asthma in 2000 is 1.97%, has risen 64.8% than the nineteen ninety.Because asthma Chang Fanfu outbreak is difficult to radical cure, so have a strong impact on the physical and mental health of infant, has also brought heavy financial burden and stress to infants ' parents.
Control for infantile asthma also is the emphasis during the child works at present.
Summary of the invention
The purpose of this invention is to provide a kind of pharmaceutical composition of treating infantile asthma.
In order to realize the object of the invention, the invention provides a kind of pharmaceutical composition of treating infantile asthma, it is characterized in that it is the medicament of being processed by weight by following bulk drugs:
1～5 part of 1～10 part of Radix Platycodonis of 1～10 part of Radix Stephaniae Tetrandrae of 1～10 part of Radix Scutellariae of Radix Bupleuri
1～10 part of 1～10 part of Fructus Forsythiae of 1～5 part of Olibanum of 1～10 part of Radix Angelicae Sinensis of Fructus Schisandrae Chinensis
1～10 part of 1～5 part of Radix Wikstroemae of Radix Polygoni Ciliinerve.
Preferably, the medicament processed by weight by following bulk drugs of Chinese medicine composition of the present invention:
3 parts of 6 parts of Radix Platycodoniss of 5 parts of Radixs Stephaniae Tetrandrae of 5 parts of Radix Scutellariaes of Radix Bupleuri
10 parts of 5 parts of Fructus Forsythiaes of 2 parts of Olibanums of 10 parts of Radix Angelicae Sinensis of Fructus Schisandrae Chinensis
5 parts of 5 parts of Radix Wikstroemae of Radix Polygoni Ciliinerve.
Pharmaceutical composition of the present invention can be processed various dosage forms with pharmaceutically acceptable carrier, such as tablet, capsule, soft capsule, pill, granule, drop pill or decoction etc.Can adopt preparation technique means well known in the art to accomplish preparation of drug combination of the present invention.
Described pharmaceutically acceptable carrier is well known, for being used to prepare the conventional excipients or the adjuvant of above-mentioned preparation.Excipient or adjuvant commonly used comprise (but being not limited to) filler, lubricant, dispersant, wetting agent, binding agent, antioxidant or the like; For example, syrup, arabic gum, sorbitol, lactose, dextrin, starch, calcium carbonate, Pulvis Talci, Polyethylene Glycol, carboxymethyl starch sodium, magnesium stearate or the like.
The reasonable recipe of pharmaceutical composition of the present invention, curative effect is clear and definite, can treat infantile asthma effectively.
The specific embodiment
Below description through the specific embodiment the present invention is described further; But this is not to be limitation of the present invention; Those skilled in the art are according to basic thought of the present invention; Can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get Radix Bupleuri 50 grams, Radix Scutellariae 50 grams, Radix Stephaniae Tetrandrae 60 grams, Radix Platycodonis 30 grams, Fructus Schisandrae Chinensis 100 grams, Radix Angelicae Sinensis 20 grams, Olibanum 50 grams, Fructus Forsythiae 100 grams, Radix Polygoni Ciliinerve 50 grams, Radix Wikstroemae 50 grams; The water that adds 10 times of medical material weight heated 2 hours down at 80 ℃, filtered; Filtrating is concentrated into 300 milliliters, promptly gets.
Experimental example
Diagnostic criteria
The cough variant asthma diagnostic criteria of formulating according to national pediatric asthma cooperative groups in 1998 (national pediatric asthma control association is with group. pediatric asthma control conventional (trying). and Chinese department of pediatrics magazine, 1998,36 (12); 747.) judge: cough continues or showed effect repeatedly assorted 30 days, often accompanies the ictal cough of night or early morning, and expectorant is few, and motion increases the weight of; Clinical nothing infects sign or long-term antibiotic therapy is invalid; With bronchodilator coughing fit is alleviated; Except the chronic cough that causes of other reasons; A guy or family's allergies, measurement of bronchial responsiveness, allergen detection etc. can be made auxiliary diagnosis.
20 routine infants, wherein male 10 examples, women 10 examples, reckling 2 years old, the maximum 5 years old.
Therapeutic Method:
Use the decoction of preparation among the embodiment 1, take each 30 milliliters every day 2 times.One week was 1 course of treatment.
Curative effect determinate standard:
The criterion of therapeutical effect of formulating according to Department of Medical Administration of State Administration of Traditional Chinese Medicine (Department of Medical Administration of State Administration of Traditional Chinese Medicine. the inside and outside Gynecology & Pediatrics Dept. disease diagnosis of traditional Chinese medical science criterion of therapeutical effect. Nanjing: Jiangsu science tech publishing house; 1998; 136.): clinical cure: cough and pharyngeal transference cure, do not send out again more than 2 weeks; Take a turn for the better: sx; Invalid: symptom does not have obvious improvement.
Therapeutic outcome:
After a course of treatment, whole 20 routine patients all cure.
Claims (3)
1. a pharmaceutical composition of treating infantile asthma is characterized in that, it is the medicament of being processed by weight by following bulk drugs:
1～5 part of 1～10 part of Radix Platycodonis of 1～10 part of Radix Stephaniae Tetrandrae of 1～10 part of Radix Scutellariae of Radix Bupleuri
1～10 part of 1～10 part of Fructus Forsythiae of 1～5 part of Olibanum of 1～10 part of Radix Angelicae Sinensis of Fructus Schisandrae Chinensis
1～10 part of 1～5 part of Radix Wikstroemae of Radix Polygoni Ciliinerve.
2. the pharmaceutical composition of treatment infantile asthma according to claim 1 is characterized in that, it is the medicament of being processed by weight by following bulk drugs:
3 parts of 6 parts of Radix Platycodoniss of 5 parts of Radix Stephaniae Tetrandrae of 5 parts of Radix Scutellariaes of Radix Bupleuri
10 parts of 5 parts of Fructus Forsythiaes of 2 parts of Olibanums of 10 parts of Radix Angelicae Sinensis of Fructus Schisandrae Chinensis
5 parts of 5 parts of Radix Wikstroemae of Radix Polygoni Ciliinerve.
3. the pharmaceutical composition of treatment infantile asthma according to claim 1 and 2 is characterized in that said medicament is tablet, capsule, soft capsule, pill, granule, drop pill or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110407152 CN102488788B (en) | 2011-12-09 | 2011-12-09 | Medicinal composition for treating asthma in children |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110407152 CN102488788B (en) | 2011-12-09 | 2011-12-09 | Medicinal composition for treating asthma in children |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102488788A true CN102488788A (en) | 2012-06-13 |
| CN102488788B CN102488788B (en) | 2013-07-17 |
Family
ID=46180687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110407152 Expired - Fee Related CN102488788B (en) | 2011-12-09 | 2011-12-09 | Medicinal composition for treating asthma in children |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102488788B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103446400A (en) * | 2013-09-25 | 2013-12-18 | 岳素敏 | Traditional Chinese medicine preparation for treating asthma |
-
2011
- 2011-12-09 CN CN 201110407152 patent/CN102488788B/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 邢向晖等: "中医药治疗小儿支气管哮喘概况", 《山东中医药大学学报》 * |
| 郭辉等: "乳香抗哮喘有效部位化学成分的研究", 《中草药》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103446400A (en) * | 2013-09-25 | 2013-12-18 | 岳素敏 | Traditional Chinese medicine preparation for treating asthma |
| CN103446400B (en) * | 2013-09-25 | 2015-05-13 | 岳素敏 | Traditional Chinese medicine preparation for treating asthma |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102488788B (en) | 2013-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101700307B (en) | Traditional Chinese medicine for curing chronic pharyngolaryngitis | |
| CN104274637A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
| CN102258726A (en) | Traditional Chinese medicine composition for treating tuberculosis | |
| CN102488788B (en) | Medicinal composition for treating asthma in children | |
| CN102657706A (en) | Infantile anti-cold umbilical therapeutic ointment | |
| CN102552512A (en) | Traditional Chinese medicine used for treating hepatitis B | |
| CN102488801B (en) | Medicine composition for curing chronic gastritis | |
| CN103191385B (en) | Medicament for treating infantile asthma | |
| CN1814194B (en) | Chinese-western medicine composition for treating infant's common cold and preparation method thereof | |
| CN101129677A (en) | Quick-effective pill for hemorrhoid | |
| CN103845592A (en) | Traditional Chinese medicine for treating cervical lymph node tuberculosis | |
| CN113288992A (en) | Traditional Chinese medicine composition for preventing and/or treating diseases caused by novel coronavirus, preparation method and application thereof | |
| CN103550459B (en) | A kind of preparation method for the treatment of the medicament of infantile asthma | |
| CN103432506A (en) | Pharmaceutical composition for treating upper respiratory infection | |
| CN104474184B (en) | A kind of drug for treating cough after common cold | |
| CN103041362A (en) | Drug for treating rheumatism and rheumatoid and preparation method thereof | |
| CN102488797B (en) | Medicinal composition for treating dysmenorrhea | |
| CN106491692A (en) | A kind of coldrex | |
| CN107349303B (en) | Traditional Chinese medicine composition for treating chronic chest pain and application thereof | |
| CN100457177C (en) | Chinese medicinal health-care preparation for cloaring lung, supplementing kidney | |
| CN103520386B (en) | Preparation method of medicine composition used for treating children asthma | |
| CN104906527A (en) | Traditional Chinese medicine composition for treating infantile asthma | |
| CN104055886A (en) | Medicinal composition for treating chronic cough, and preparation method and application thereof | |
| CN104971298A (en) | Pyrrosia leaf traditional Chinese medicine composition for treating phlegm-heat lung obstructing type asthma | |
| CN106031781A (en) | Traditional Chinese medicine composition for the treatment of asthma in children |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: JIANGSU NEWHOPE RENEWABLE ENERGY S+T CO., LTD. Free format text: FORMER OWNER: MENG LIANGLIANG Effective date: 20131129 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272111 JINING, SHANDONG PROVINCE TO: 213399 CHANGZHOU, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20131129 Address after: 213399 Jiangsu city of Changzhou province Liyang Liyang Town of Wuhu Shanghai Road No. 168 Patentee after: Jiangsu Newhope Renewable Energy Science & Technology Co., Ltd. Address before: 272111 No. 6 health Road, pediatrics, Jining first people's Hospital, Shandong, Shandong, Jining Province, China Patentee before: Meng Jingjing |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130717 Termination date: 20151209 |
|
| EXPY | Termination of patent right or utility model |